ADAS-Cog

(redirected from Alzheimer Disease Assessment Scale-Cognitive)

ADAS-Cog

An 11-part neurological testing instrument used to assess patients with Alzheimer’s disease. ADAS-Cog is used as a primary outcome measure in many drug trials, and regarded as the best brief exam for assessing language and memory skills.

Time required
30 minutes.

Pros
More thorough than Blessed or MMSE.

References in periodicals archive ?

06 ADAS-Cog: Alzheimer Disease Assessment Scale-Cognitive subscale; ADL: Activities of Daily Living; ChEIs: cholinesterase inhibitors; Gb: Ginkgo biloba; MMSE: Mini Mental State Examination; NPI: Neuropsychiatrie Inventory; ZBI: Zarit Burden Interview.

Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: data from the ICTUS study

These differences are highly statistically significant, but the effect size is small: No trial has found a 2-point difference on the 30-point Mini-Mental State Examination or a 4-point difference on the 70-point Alzheimer Disease Assessment Scale-cognitive subscale.

Assessing cholinesterase inhibitors

The primary endpoint for this objective was the Alzheimer Disease Assessment Scale-Cognitive Subscale (ADAS-Cog), a standardized measure of cognitive skills used by neurologists to track the course of Alzheimer disease.